NCT01511575View on ClinicalTrials.gov

Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Leukemia
Interventions
GENETIC

RNA analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT01511575 - Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder | Biotech Hunter | Biotech Hunter